The presentations will include new findings on mogamulizumab’s therapeutic benefit, safety, and pharmacodynamic profile, and insight into alternative dosing strategies, real-world treatment patterns, ...
Survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) reported lasting sequelae with insufficient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback